Prediction models identify risk factors for cardiovascular disease mortality in maintenance hemodialysis patients, suggesting tools for clinical assessment.
In conclusion, this study consistently identified serum albumin, procalcitonin, and myoglobin as key factors associated with CVD mortality risk in MHD patients. Both models demonstrated promising predictive performance in our cohort. These findings suggest the potential of such models to inform clinical risk assessment. However, external validation in larger, multi-center studies is necessary before these tools can be considered for direct clinical decision-making.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: